Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CTCXNASDAQ:ICCMNASDAQ:MDAINASDAQ:TMDI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTCXCarmell$2.64-0.4%$1.34$0.17▼$2.19$55.19M0.513.96 million shs44,133 shsICCMIceCure Medical$0.97-1.7%$1.08$0.48▼$1.66$54.00M0.33467,245 shs206,866 shsMDAISpectral AI$1.97-7.5%$1.42$0.82▼$3.25$49.87M0.7523,400 shs453,892 shsTMDITitan Medical$0.14-26.3%$0.23$0.13▼$1.20$15.67M2.364.83 million shs7.71 million shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTCXCarmell-1.12%-18.46%+1,986.61%+935.16%+26.79%ICCMIceCure Medical-3.88%-1.00%-4.50%-30.28%+32.00%MDAISpectral AI+3.90%+19.66%+50.00%+37.42%+26.79%TMDITitan Medical0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTCXCarmellN/AN/AN/AN/AN/AN/AN/AN/AICCMIceCure Medical3.2209 of 5 stars3.85.00.00.03.40.00.6MDAISpectral AI3.6539 of 5 stars3.75.00.00.03.33.30.0TMDITitan MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTCXCarmell 0.00N/AN/AN/AICCMIceCure Medical 3.50Strong Buy$2.50156.94% UpsideMDAISpectral AI 3.33Buy$4.75141.12% UpsideTMDITitan Medical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest TMDI, CTCX, ICCM, and MDAI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/29/2025ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.504/2/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.503/28/2025ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.50 ➝ $2.503/18/2025MDAISpectral AIHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.50 ➝ $3.50(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTCXCarmell$32.84K1,680.60N/AN/A$1.07 per share2.47ICCMIceCure Medical$3.27M16.50N/AN/A$0.27 per share3.60MDAISpectral AI$29.96M1.66N/AN/A($0.10) per share-19.70TMDITitan Medical$20.09M0.78N/AN/A$0.32 per share0.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTCXCarmell-$15.44MN/A0.00∞N/AN/A-217.50%-50.22%N/AICCMIceCure Medical-$14.65M-$0.28N/AN/AN/A-376.85%-124.44%-87.70%8/19/2025 (Estimated)MDAISpectral AI-$20.85M-$0.54N/AN/AN/A-40.78%N/A-77.87%N/ATMDITitan Medical-$14.86M-$0.19N/A∞N/AN/A-167.03%-112.15%N/ALatest TMDI, CTCX, ICCM, and MDAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/28/2025Q1 2025ICCMIceCure Medical-$0.08-$0.06+$0.02-$0.06$0.75 million$0.73 million3/27/2025Q4 2024ICCMIceCure Medical-$0.07-$0.08-$0.01-$0.08$1.07 million$1.07 million3/27/2025Q4 2024MDAISpectral AI-$0.13-$0.06+$0.07-$0.41$6.83 million$7.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTCXCarmellN/AN/AN/AN/AN/AICCMIceCure MedicalN/AN/AN/AN/AN/AMDAISpectral AIN/AN/AN/AN/AN/ATMDITitan MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTCXCarmellN/A0.310.29ICCMIceCure Medical0.022.672.27MDAISpectral AIN/A0.730.69TMDITitan MedicalN/A1.411.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTCXCarmell24.22%ICCMIceCure Medical0.62%MDAISpectral AI67.08%TMDITitan Medical3.55%Insider OwnershipCompanyInsider OwnershipCTCXCarmell29.00%ICCMIceCure Medical2.44%MDAISpectral AI30.70%TMDITitan Medical0.02%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTCXCarmell1420.91 million14.84 millionNot OptionableICCMIceCure Medical6055.50 million54.15 millionNot OptionableMDAISpectral AI8325.32 million8.04 millionNot OptionableTMDITitan Medical49111.95 million111.93 millionNot OptionableTMDI, CTCX, ICCM, and MDAI HeadlinesRecent News About These CompaniesConavi Medical Corp. Commences Trading on TSX-V Under Symbol “CNVI”October 18, 2024 | markets.businessinsider.comTitan Submersible HearingsSeptember 25, 2024 | msn.com'All good here' was 1 of the final texts sent from the doomed Titan submersibleSeptember 17, 2024 | news8000.comMedi Assist, Tata Elxsi, Tata Tech, ABB India Gain While Titan, Minda Corp, Syngene Slump In tradeAugust 27, 2024 | msn.comMasculen Titan ME Review – Is It Really Worth Buying?August 21, 2024 | thedailyworld.comTitan Enterprises Releases New Display Model of its Popular Pulsite® Link Flow InstrumentAugust 16, 2024 | msn.comTitan Medical Inc.: Titan Medical Reports Operating and Financial Results for the Second Quarter 2024August 16, 2024 | finanznachrichten.deTitan Pharmaceuticals: Q1 Earnings SnapshotMay 15, 2024 | smdailyjournal.comTitan Medical Inc.: Titan Medical Reports Financial Results for the First Quarter 2024May 13, 2024 | finanznachrichten.deTMD:CA Titan Medical Inc.April 21, 2024 | seekingalpha.comTitan Medical Inc.: Titan Medical Reports Fiscal Year 2023 ResultsApril 1, 2024 | finanznachrichten.deTitan Medical signs deal to merge with Conavi MedicalMarch 21, 2024 | msn.comTitan Medical Inc TMDIFFebruary 27, 2024 | morningstar.comPerifery appoints Titan Data Solutions as authorised distributorFebruary 13, 2024 | advanced-television.comTitan Medical Inc (TMD)February 13, 2024 | investing.comVantage Titan 3T MRI Scanner from ToshibaJanuary 11, 2024 | news-medical.netAttack on Titan: Hajime Isayama Will Create New Titan Story in 2024October 3, 2023 | comicbook.comFive dead on Titan sub were 'true explorers' - OceanGateSeptember 28, 2023 | bbc.comTMDIF Titan Medical Inc.August 1, 2023 | seekingalpha.comFalse claim Titan passenger was the vice chairman of the World Economic Forum | Fact checkJuly 25, 2023 | usatoday.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTMDI, CTCX, ICCM, and MDAI Company DescriptionsCarmell NASDAQ:CTCX$2.64 -0.01 (-0.38%) As of 06/12/2025Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.IceCure Medical NASDAQ:ICCM$0.97 -0.02 (-1.72%) Closing price 03:58 PM EasternExtended Trading$0.98 +0.00 (+0.21%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Spectral AI NASDAQ:MDAI$1.97 -0.16 (-7.51%) Closing price 04:00 PM EasternExtended Trading$2.03 +0.06 (+3.25%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.Titan Medical NASDAQ:TMDITitan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
